| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CARDINAL HEALTH INC | 152,500 | 11,849,000 | 0.46% | ||
| 52 | SANOFI | 305,000 | 11,648,000 | 0.45% | ||
| 53 | SABRA HEALTH CARE REIT INC | 456,190 | 11,487,000 | 0.44% | ||
| 54 | PHYSICIANS RLTY TR | 530,672 | 11,431,000 | 0.44% | ||
| 55 | BECTON DICKINSON & CO | 63,078 | 11,337,000 | 0.44% | ||
| 56 | CIGNA CORPORATION | 86,400 | 11,260,000 | 0.43% | ||
| 57 | UNITED THERAPEUTICS | 93,100 | 10,993,000 | 0.42% | ||
| 58 | VENTAS INC | 152,491 | 10,770,000 | 0.41% | ||
| 59 | DAVITA INC | 161,100 | 10,644,000 | 0.41% | ||
| 60 | PARATEK PHARMACEUTICALS INC | 762,581 | 9,921,000 | 0.38% | ||
| 61 | ENDOLOGIX INC | 773,500 | 9,901,000 | 0.38% | ||
| 62 | NATERA INC | 882,358 | 9,803,000 | 0.38% | ||
| 63 | CHARLES RIV LABS INTL INC | 115,000 | 9,584,000 | 0.37% | ||
| 64 | GALAPAGOS NV | 147,738 | 9,553,000 | 0.37% | ||
| 65 | SUPERNUS PHARMACEUTICALS INC | 2,000,000 | 9,334,000 | 0.36% | PRN | |
| 66 | ARDELYX INC COM | 707,636 | 9,157,000 | 0.35% | ||
| 67 | Foamix Pharmaceuticals Ltd. | 966,065 | 8,946,000 | 0.34% | ||
| 68 | AEGERION PHARMACEUTICALS INC | 13,000,000 | 8,572,000 | 0.33% | PRN | |
| 69 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 624,288 | 7,741,000 | 0.30% | ||
| 70 | Pieris Pharmaceuticals | 4,145,958 | 7,587,000 | 0.29% | ||
| 71 | CELLECTIS S A | 310,250 | 7,471,000 | 0.29% | ||
| 72 | RETROPHIN INC COM | 329,949 | 7,384,000 | 0.28% | ||
| 73 | HCA HOLDINGS INC | 95,684 | 7,237,000 | 0.28% | ||
| 74 | EXELIXIS INC | 551,647 | 7,056,000 | 0.27% | ||
| 75 | ARIAD PHARMACEUTICALS INC | 502,000 | 6,872,000 | 0.26% | ||
| 76 | SAGE THERAPEUTICS | 146,800 | 6,760,000 | 0.26% | ||
| 77 | ULTRAGENYX PHARMACEUTICAL INC COM | 88,400 | 6,271,000 | 0.24% | ||
| 78 | EGALET CORP | 7,000,000 | 5,963,000 | 0.23% | PRN | |
| 79 | PRA HEALTH SCIENCES INC | 102,000 | 5,764,000 | 0.22% | ||
| 80 | XENON PHARMACEUTICALS INC | 700,000 | 5,670,000 | 0.22% | ||
| 81 | ICON PLC | 72,000 | 5,571,000 | 0.21% | ||
| 82 | LTC PPTYS INC COM | 106,212 | 5,522,000 | 0.21% | ||
| 83 | JUNO THERAPEUTICS INCORPORATED | 182,000 | 5,462,000 | 0.21% | ||
| 84 | VITAE PHARMACEUTICALS INC | 250,000 | 5,230,000 | 0.20% | ||
| 85 | DEPOMED INC | 200,000 | 4,998,000 | 0.19% | ||
| 86 | NEW SR INVEST GRP INC COM | 430,997 | 4,974,000 | 0.19% | ||
| 87 | KARYOPHARM THERAPEUTICS INC COM | 500,324 | 4,868,000 | 0.19% | ||
| 88 | VALEANT PHARMACEUTICALS INTL | 192,000 | 4,714,000 | 0.18% | ||
| 89 | MERUS N V | 260,000 | 4,355,000 | 0.17% | ||
| 90 | MALLINCKRODT PUB LTD CO SHS | 61,900 | 4,319,000 | 0.17% | ||
| 91 | ALLERGAN PLC | 5,000 | 4,108,000 | 0.16% | ||
| 92 | ADAPTIMMUNE THERAPEUTICS PLC | 566,368 | 3,993,000 | 0.15% | ||
| 93 | AKORN INC | 145,235 | 3,959,000 | 0.15% | ||
| 94 | EPIZYME INC COM | 400,000 | 3,936,000 | 0.15% | ||
| 95 | TENET HEALTHCARE CORP | 164,500 | 3,728,000 | 0.14% | ||
| 96 | DYNAVAX TECHNOLOGIES CORP | 345,050 | 3,620,000 | 0.14% | ||
| 97 | BEIGENE LTD | 116,707 | 3,596,000 | 0.14% | ||
| 98 | ACADIA PHARMACEUTICALS INC COM | 111,800 | 3,556,000 | 0.14% | ||
| 99 | COMMUNITY HEALTH SYS INC NEW COM | 304,472 | 3,514,000 | 0.14% | ||
| 100 | PERRIGO CO PLC | 37,300 | 3,444,000 | 0.13% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-156805, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
